Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters

被引:24
|
作者
Colabufo, Nicola A. [1 ]
Contino, Marialessandra [1 ]
Cantore, Mariangela [1 ,2 ]
Capparelli, Elena [1 ]
Perrone, Maria Grazia [1 ]
Cassano, Giuseppe [3 ]
Gasparre, Giuseppe [3 ]
Leopoldo, Marcello [1 ]
Berardi, Francesco [1 ]
Perrone, Roberto [1 ]
机构
[1] Univ Bari ALDO MORO, Dipartimento Farm, I-70125 Bari, Italy
[2] Natl Canc Inst, Clin Expt Oncol Lab, I-70124 Bari, Italy
[3] Univ Bari ALDO MORO, Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, I-70125 Bari, Italy
关键词
P-glycoprotein; Naphthalenyl derivatives; BCRP; MRP1; MDR revertant agents; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CANCER; INHIBITORS; MRP1; BCRP; RADIOTRACER; MODULATION; DESIGN; ASSAYS;
D O I
10.1016/j.bmc.2012.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substituted naphthalenyl derivatives bearing oxazole, or thiazole or furyl heteronuclei have been carried out as bioisosters of aryl-oxazoles and -thiazoles derivatives previously reported in order to investigate the role of the hindrance on the activity towards P-gp/BCRP/and MRP1 transporters. In addition, the role of naphthalenyl group to modulate P-gp intrinsic activity of these compounds was ascertained. The results demonstrated that all naphthalenyl derivatives displayed comparable P-gp activity with respect to lead compounds previously characterized in our SAR studies but were less active towards BCRP and MRP1 pumps. In terms of intrinsic activity, the replacement of aryl with naphthalenyl moiety led to P-gp inhibitors, unambiguous or ambiguous substrates on the base of the heteronucleus and the substituent on the naphthalenyl fragment. Indeed, oxazole derivatives were: inhibitors (R = H, F, OH), unambiguous substrates (R = OCH3), or ambiguous substrate (R = Br); thiazole derivatives were: unambiguous substrates (R = OCH3, Br), or ambiguous substrates (R = H, F). Finally furyl derivatives were ambiguous substrates. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1324 / 1332
页数:9
相关论文
共 50 条
  • [31] Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos
    A. Konieczna
    B. Erdösová
    R. Lichnovská
    M. Jandl
    K. Čížková
    J. Ehrmann
    Journal of Molecular Histology, 2011, 42 : 567 - 574
  • [32] Could efflux pumps P-gp, MRP1 and BCRP have predictive and prognostic value for the neoadjuvant chemotherapy in patients with non-small cell lung carcinoma
    Stojsic, J.
    Stankovic, T.
    Milosevic, Z.
    Milovanovic, Z.
    Milinkovic, V.
    Stojkovic, S.
    Dinic, J.
    Pesic, M.
    Renic, A. Podolski
    Tanic, N.
    VIRCHOWS ARCHIV, 2017, 471 : S107 - S107
  • [33] 人脑胶质瘤中耐药蛋白P-gp和MRP1的表达
    王存祖
    赵竹青
    杭健育
    徐光明
    江苏医药, 2003, (05) : 341 - 343+317
  • [34] Redox-mediated P-gp and MRP1 transport activity in human CD19+lymphocytes
    Tamashevski, A.
    FEBS JOURNAL, 2014, 281 : 499 - 499
  • [35] Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP
    Lempers, Vincent J. C.
    van den Heuvel, Jeroen J. M. W.
    Russel, Frans G. M.
    Aarnoutse, Rob E.
    Burger, David M.
    Bruggemann, Roger J.
    Koenderink, Jan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3372 - 3379
  • [36] Differential involvement of P-gp, MRP2 and BCRP on the absorption of CKD-602 and topotecan
    Li, Hong
    Kim, Dae-Duk
    Chung, Suk-Jae
    Shim, Chang-Koo
    DRUG METABOLISM REVIEWS, 2006, 38 : 75 - 76
  • [37] Interaction of structurally diverse pesticides with multidrug resistance proteins (P-gp, MRP2, and BCRP)
    Pusalkar, Sandeepraj
    Williams, David A.
    LeDuc, Barbara
    Liu, Ning
    Xia, Cindy
    DRUG METABOLISM REVIEWS, 2006, 38 : 243 - 243
  • [38] P-gP and MRP immunostaining in gliomas - does the expression of P-gP and MRP correlate with chemosensitivity in glioma cell cultures?
    Sutton, C.
    Ashton, K.
    Dawson, T. P.
    BRAIN PATHOLOGY, 2010, 20 : 55 - 56
  • [39] Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte
    Takebayashi, Y
    Nakayama, K
    Fujioka, T
    Kanzaki, A
    Mutho, M
    Uchida, T
    Miyazaki, K
    Ito, M
    Fukumoto, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (04) : 397 - 400
  • [40] Chalcogenopyrylium Compounds as Modulators of the ATP-Binding Cassette Transporters P-Glycoprotein (P-gp/ABCB1) and Multidrug Resistance Protein 1 (MRP1/ABCC1)
    Ebert, Sean P.
    Wetzel, Bryan
    Myette, Robert L.
    Conseil, Gwenaelle
    Cole, Susan P. C.
    Sawada, Geri A.
    Loo, Tip W.
    Bartlett, M. Claire
    Clarke, David M.
    Detty, Michael R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4683 - 4699